Bioventus

Bioventus

Health Care Equipment & Supplies
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.

$892.4M

Market Cap • 10/9/2026

2015

(11 years)

Founded

2021

(5 years ago)

IPO

NASDAQ

Listing Exchange

Flag of United States

United States

Country

Valuation

P/B

3,9

P/S

1,9

P/EBITDA

8,6

P/OCF

16,5

P/FCF

17,1

P/E

17

BVPS

3,3

EPS

0,8

Market Cap

Market Cap

892,4M

EV

1,3B

EV/Revenue

2,3

EV/EBITDA

12,7

EV/EBIT

22,6

Payout

Dividend Per Share

0

Dividend Yield

0%

Buyback Yield

0%

Total Yield

0%

Dividend Yield 5Y

0%

Payout

0%

Retained Earnings

-298,4M

Profitability

Gross Margin

68,7%

EBITDA Margin

17,8%

EBIT Margin

10%

Net Margin

15,3%

D&A/EBITDA

0%

R&D/Revenue

2%

Capex/Revenue

0,4%

Capex/D&A

5,7%

Capex/OCF

3,9%

SBC/OCF

15,4%

% PPE

3,7%

% Goodwill

1,1%

ROE

37,1%

ROIC

11,1%

Growth

CAGR Revenue 5Y

9,1%

CAGR Op. Income 5Y

14,9%

CAGR Net Income 5Y

29,9%

CAGR EPS 5Y

-0,3%

CAGR OCF 5Y

-1,5%

Leverage

N.D./EBITDA

2,1

Debt/Equity

0%

Current Ratio

1,2

Quick Ratio

1,1

Interest Coverage

293,2%

Premium

Unlock 100% of the data and have immediate access on more than 6.000 companies with updated information!
  • Unrestricted access
  • Unlimited data history
  • Analysis videos
  • Quarterly highlights
  • Customizable financials table
  • Ranking
  • Discussions

...and much more!

Get Premium